New Jersey Attorney General Targets Industry Ties To Clinical Investigators
This article was originally published in The Gray Sheet
Executive Summary
The attorney general of New Jersey is going after the device industry for failures to disclose possible financial conflicts of interest with clinical trial investigators, and wants FDA to strengthen its enforcement, as well